世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

Middle East & Africa Infectious Disease Diagnostics Market Forecast to 2030 - Regional Analysis - By Product (Kits & Reagents, Instruments, and Software & Services), Technology (Biosensor-Based, Immunodiagnostics, Molecular-Based Diagnostic Techniques, Clinical Biology, and Others), Application Type (Laboratory Testing and Point-of-Care Testing), Testing Type (Human Testing and Veterinary Testing), and End User (Diagnostic Laboratories, Hospitals & Clinics, Research Institutes, Homecare Settings, and Others)


The Middle East & Africa infectious disease diagnostics market was valued at US$ 1,193.19 million in 2022 and is expected to reach US$ 1,576.80 million by 2030; it is estimated to grow at a CAGR of... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
The Insight Partners
ザ・インサイトパートナーズ
2024年3月14日 US$3,550
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
122 英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

Summary

The Middle East & Africa infectious disease diagnostics market was valued at US$ 1,193.19 million in 2022 and is expected to reach US$ 1,576.80 million by 2030; it is estimated to grow at a CAGR of 3.5% from 2022 to 2030.

Rising Incidence of Infectious Diseases Drive Middle East & Africa Infectious Disease Diagnostics Market

Fungi, viruses, parasites, bacteria, and toxic products are among the infectious agents that can cause infectious diseases. Public health is adversely affected by infectious diseases, causing morbidity, mortality, and economic burdens. Rising incidence of infectious diseases propels the requirement for accurate and timely diagnosis to form the basis for effective disease management, treatment, and prevention. Diagnosing and monitoring multiple infections and diseases, including hepatitis C, HIV, tuberculosis, human papillomavirus, and sexually transmitted infections (STIs), and infectious disease outbreaks can be performed using molecular diagnostics techniques, laboratory-based assays, and point-of-care tests. According to the Centers for Disease Control and Prevention (CDC), ~10.2 million people visited physician offices for the treatment of infectious and parasitic diseases in African countries every year. According to an article published in the National Library of Medicine (NLM) in 2021, infectious diseases are a major concern in most African countries due to high disease burden and limited healthcare resources. More than 200 pathogens can cause fever in Nigeria, one of the most common reasons for visiting a healthcare facility. According to the World Health Organization (WHO), ~58 million people across the world suffer from chronic hepatitis C infection, and ~1.5 million new infections are diagnosed every year. HIV is a major public health issue across the world. According to The Joint United Nations Program on HIV/AIDS (UNAIDS), in 2020, ~ 37.7 million people had HIV. Out of these, ~36 million people were adults, and about 1.7 million were children aged 0-14 years. Also, ~1.5 million new HIV cases were reported globally in 2020. According to WHO, tuberculosis (TB) is the 13th leading cause of death across the world, and it is the second leading infectious disease that leads to death after COVID-19. According to the WHO, 1.5 million deaths were caused by TB in 2020. In 2020, WHO projected that 10 million people had TB across the world, Furthermore, in 2020, 30 countries with high TB burdens accounted for 86% of new TB cases. Thus, the upsurging incidence of infectious diseases bolsters the need for infectious disease diagnostic technologies, such as microbial culture, hemagglutination inhibition tests, and enzyme-linked immunosorbent assays (ELISA).

Middle East & Africa Infectious Disease Diagnostics Market Overview

The Rest of Middle East & Africa includes Israel, Iran, Iraq, Kuwait, Oman, Egypt, and Kenya. Increasing demand for infectious disease diagnostics and growing technological advancement in clinical diagnostic technologies are boosting the market growth in the Middle Eastern and Africa. Moreover, the presence of major market players in the countries in the Rest of Middle East and Africa is fueling the growth of the market. for instance, Todos Medical Ltd. is a leading company in Israel that deals with providing life-saving diagnostic solutions for the early detection of various diseases. In 2021, the company has announced its first commercial antibody test for COVID-19. Thus, the presence of players offering products and end users related, the development and innovation of diagnostic solutions in various countries of the region is further likely to be responsible for supporting the overall growth of the market.

Middle East & Africa Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Million)

Middle East & Africa Infectious Disease Diagnostics Market Segmentation

The Middle East & Africa infectious disease diagnostics market is segmented based on product, technology, application type, testing type, end user, and country.

Based on product, the Middle East & Africa infectious disease diagnostics market is segmented into kits & reagents, instruments, and software & services. The kits & reagents segment held the largest share in 2022.

By technology, the Middle East & Africa infectious disease diagnostics market is segmented into biosensor-based, immunodiagnostics, molecular-based diagnostic techniques, clinical biology, and others. The immunodiagnostics segment held the largest share in 2022. The molecular-based diagnostic techniques segment is further subsegmented into enzyme-linked immunosorbent assay (ELISA), western blotting analysis, and immunofluorescence assay. The molecular-based diagnostic techniques segment is further subsegmented into polymerase chain reaction (PCR), in situ hybridization, isothermal nucleic acid amplification technology (INAAT), next-generation sequencing (NGS), DNA microarrays, and others.

By application type, the Middle East & Africa infectious disease diagnostics market is bifurcated into laboratory testing and point-of-care testing. The laboratory testing segment held a larger share in 2022.

By testing type, the Middle East & Africa infectious disease diagnostics market is bifurcated into human testing and veterinary testing. The human testing segment held a larger share in 2022. The human testing segment is further subsegmented into HIV, hepatitis, HAIs, HPV, tuberculosis, influenza, and others.

By end user, the Middle East & Africa infectious disease diagnostics market is segmented into diagnostic laboratories, hospitals & clinics, research institutes, homecare settings, and others. The diagnostic laboratories segment held the largest share in 2022.

Based on country, the Middle East & Africa infectious disease diagnostics market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. The Rest of Middle East & Africa dominated the Middle East & Africa infectious disease diagnostics market in 2022.

Abbott Laboratories, Bruker Corp, Cardinal Health Inc, F. Hoffmann-La Roche Ltd, Trinity Biotech Plc, Danaher Corp, Bio-Rad Laboratories Inc, ACON Laboratories Inc, and DiaSorin SpA are some of the leading companies operating in the Middle East & Africa infectious disease diagnostics market.

ページTOPに戻る


Table of Contents

TABLE OF CONTENTS

1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
2.2 Middle East & Africa Infectious Disease Diagnostics Market, by Geography (US$ Million)
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East & Africa Infectious Disease Diagnostics Market Landscape
4.1 Overview
4.2 Middle East & Africa PEST Analysis
5. Middle East & Africa Infectious Disease Diagnostics Market - Key Industry Dynamics
5.1 Market Drivers:
5.1.1 Rising Incidence of Infectious Diseases
5.1.2 Rising Application of Diagnostics in Veterinary Infectious Disease
5.2 Market Restraints
5.2.1 Inadequate Reimbursement Scenario
5.3 Market Opportunities
5.3.1 Increasing Focus on R&D and Funding in Infectious Disease Diagnostics
5.4 Future Trends
5.4.1 Rising Number of Product Approvals and Launches
5.5 Impact Analysis:
6. Infectious Disease Diagnostics Market - Middle East & Africa Market Analysis
6.1 Middle East & Africa Infectious Disease Diagnostics Market Revenue (US$ Mn), 2022 - 2030
7. Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 - by Product
7.1 Overview
7.2 Middle East & Africa Infectious Disease Diagnostics Market Revenue Share, by Product, 2022 & 2030 (%)
7.3 Kits & Reagents
7.3.1 Overview
7.3.2 Kits & Reagents: Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Instruments
7.4.1 Overview
7.4.2 Instruments: Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Software & Services
7.5.1 Overview
7.5.2 Software & Services: Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8. Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 - by Technology
8.1 Overview
8.2 Middle East & Africa Infectious Disease Diagnostics Market Revenue Share, by Technology, 2022 & 2030 (%)
8.3 Biosensor-based
8.3.1 Overview
8.3.2 Biosensor-based: Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Immunodiagnostics
8.4.1 Overview
8.4.2 Immunodiagnostics: Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.4.2.1 Middle East & Africa Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million)
8.5 Molecular-Based Diagnostic Techniques
8.5.1 Overview
8.5.2 Molecular-Based Diagnostic Techniques: Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.5.2.1 Middle East & Africa Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million)
8.6 Clinical Biology
8.6.1 Overview
8.6.2 Clinical Biology: Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
9. Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 - by Application Type
9.1 Overview
9.2 Middle East & Africa Infectious Disease Diagnostics Market Revenue Share, by Application Type, 2022 & 2030 (%)
9.3 Point-of-Care Testing
9.3.1 Overview
9.3.2 Point-of-Care Testing: Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Laboratory Testing
9.4.1 Overview
9.4.2 Laboratory Testing: Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10. Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 - by Testing Type
10.1 Overview
10.2 Middle East & Africa Infectious Disease Diagnostics Market Revenue Share, by Testing Type, 2022 & 2030 (%)
10.3 Human Testing
10.3.1 Overview
10.3.2 Human Testing: Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.3.2.1 Middle East & Africa Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million)
10.4 Veterinary Testing
10.4.1 Overview
10.4.2 Veterinary Testing: Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
11. Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 - by End User
11.1 Overview
11.2 Middle East & Africa Infectious Disease Diagnostics Market Revenue Share, by End User, 2022 & 2030 (%)
11.3 Diagnostic Laboratories
11.3.1 Overview
11.3.2 Diagnostic Laboratories: Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
11.4 Hospitals and Clinics
11.4.1 Overview
11.4.2 Hospitals and Clinics: Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
11.5 Research Institutes
11.5.1 Overview
11.5.2 Research Institutes: Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
11.6 Homecare Settings
11.6.1 Overview
11.6.2 Homecare Settings: Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
11.7 Others
11.7.1 Overview
11.7.2 Others: Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
12. Middle East & Africa Infectious Disease Diagnostics Market - Country Analysis
12.1 Middle East & Africa Infectious Disease Diagnostics Market - Country Analysis
12.1.1 Middle East & Africa Infectious Disease Diagnostics Market, by Country
12.1.1.1 Saudi Arabia
12.1.1.1.1 Overview
12.1.1.1.2 Saudi Arabia: Middle East & Africa Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
12.1.1.1.3 Saudi Arabia: Middle East & Africa Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million)
12.1.1.1.4 Saudi Arabia: Middle East & Africa Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million)
12.1.1.1.4.1 Saudi Arabia: Middle East & Africa Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million)
12.1.1.1.4.2 Saudi Arabia: Middle East & Africa Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million)
12.1.1.1.5 Saudi Arabia: Middle East & Africa Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million)
12.1.1.1.6 Saudi Arabia: Middle East & Africa Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million)
12.1.1.1.6.1 Saudi Arabia: Middle East & Africa Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million)
12.1.1.1.7 Saudi Arabia: Middle East & Africa Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million)
12.1.1.2 South Africa
12.1.1.2.1 Overview
12.1.1.2.2 South Africa: Middle East & Africa Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
12.1.1.2.3 South Africa: Middle East & Africa Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million)
12.1.1.2.4 South Africa: Middle East & Africa Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million)
12.1.1.2.4.1 South Africa: Middle East & Africa Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million)
12.1.1.2.4.2 South Africa: Middle East & Africa Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million)
12.1.1.2.5 South Africa: Middle East & Africa Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million)
12.1.1.2.6 South Africa: Middle East & Africa Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million)
12.1.1.2.6.1 South Africa: Middle East & Africa Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million)
12.1.1.2.7 South Africa: Middle East & Africa Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million)
12.1.1.3 UAE
12.1.1.3.1 Overview
12.1.1.3.2 UAE: Middle East & Africa Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
12.1.1.3.3 UAE: Middle East & Africa Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million)
12.1.1.3.4 UAE: Middle East & Africa Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million)
12.1.1.3.4.1 UAE: Middle East & Africa Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million)
12.1.1.3.4.2 UAE: Middle East & Africa Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million)
12.1.1.3.5 UAE: Middle East & Africa Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million)
12.1.1.3.6 UAE: Middle East & Africa Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million)
12.1.1.3.6.1 UAE: Middle East & Africa Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million)
12.1.1.3.7 UAE: Middle East & Africa Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million)
12.1.1.4 Rest of Middle East & Africa
12.1.1.4.1 Overview
12.1.1.4.2 Rest of Middle East & Africa: Middle East & Africa Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
12.1.1.4.3 Rest of Middle East & Africa: Middle East & Africa Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million)
12.1.1.4.4 Rest of Middle East & Africa: Middle East & Africa Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million)
12.1.1.4.4.1 Rest of Middle East & Africa: Middle East & Africa Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million)
12.1.1.4.4.2 Rest of Middle East & Africa: Middle East & Africa Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million)
12.1.1.4.5 Rest of Middle East & Africa: Middle East & Africa Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million)
12.1.1.4.6 Rest of Middle East & Africa: Middle East & Africa Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million)
12.1.1.4.6.1 Rest of Middle East & Africa: Middle East & Africa Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million)
12.1.1.4.7 Rest of Middle East & Africa: Middle East & Africa Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million)
13. Industry Landscape
13.1 Overview
13.2 Growth Strategies Done by the Companies in the Market, (%)
13.3 Organic Developments
13.3.1 Overview
13.4 Inorganic Developments
13.4.1 Overview
14. Company Profiles
14.1 Abbott Laboratories
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Bruker Corp
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Cardinal Health Inc
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 F. Hoffmann-La Roche Ltd
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Trinity Biotech Plc
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Danaher Corp
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Bio-Rad Laboratories Inc
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 ACON Laboratories Inc
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 DiaSorin SpA
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
15. Appendix
15.1 About Us
15.2 Glossary of Terms

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(医療)の最新刊レポート

The Insight Partners社のバイオテクノロジー分野での最新刊レポート


よくあるご質問


The Insight Partners社はどのような調査会社ですか?


The Insight Partnersはインドに本社を置く調査会社です。経験豊富な専門家チームを通じて、お客様に最適な調査と分析を提供することに専念しています。幅広い分野をカバーしていますがヘルスケ... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/12/20 10:28

158.95 円

165.20 円

201.28 円

ページTOPに戻る